Junji Moriya Selected Research

bu-zhong-yi-qi-tang

1/2020	Neuroinflammation, Oxidative Stress, and Neurogenesis in a Mouse Model of Chronic Fatigue Syndrome, and the Treatment with Kampo Medicine.
6/2009	Hochu-ekki-to combined with interferon-gamma moderately enhances daily activity of chronic fatigue syndrome mice by increasing NK cell activity, but not neuroprotection.
9/2008	Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41).
1/2004	Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junji Moriya Research Topics

Disease

6	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2020 - 01/2004
6	Heart Failure 05/2010 - 12/2004
5	Schizophrenia (Dementia Praecox) 01/2012 - 07/2009
4	Inflammation (Inflammations) 01/2020 - 07/2009
4	Hyperglycemia 02/2015 - 06/2009
4	Body Weight (Weight, Body) 05/2010 - 01/2004
3	Neoplasms (Cancer) 01/2019 - 01/2013
3	Major Depressive Disorder (Major Depressive Disorders) 01/2016 - 01/2014
3	Ischemia 05/2014 - 05/2010
3	Obesity 10/2013 - 03/2010
3	Insulin Resistance 10/2013 - 05/2010
3	Myocarditis (Carditis) 05/2010 - 06/2007
2	Myocardial Infarction 01/2019 - 08/2012
2	Hypertension (High Blood Pressure) 08/2016 - 11/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2014 - 01/2008
2	Atrophy 01/2011 - 09/2008
1	Hepatic Encephalopathy 10/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Non-alcoholic Fatty Liver Disease 12/2019
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2019
1	Atherosclerosis 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Fever (Fevers) 01/2018
1	Cellulitis 01/2018
1	Bronchopneumonia 01/2018
1	Mycosis Fungoides 01/2018
1	Sepsis (Septicemia) 01/2018
1	Polymyositis 01/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2018
1	Pulmonary Embolism 01/2018
1	Dyslipidemias (Dyslipidemia) 08/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016
1	Abdominal Obesity 08/2016
1	Cerebral Cortical Thinning 09/2015
1	Anemia 01/2015
1	Pleural Effusion (Pleural Effusions) 01/2013
1	POEMS Syndrome (Syndrome, POEMS) 01/2013
1	Osteoarthritis 01/2013
1	Paraproteinemias (Monoclonal Gammopathy) 01/2013
1	Edema (Dropsy) 01/2013
1	Ascites 01/2013

Drug/Important Bio-Agent (IBA)

4	bu-zhong-yi-qi-tangIBA 01/2020 - 01/2004
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014 - 09/2008
4	gamma-Aminobutyric Acid (GABA)IBA 12/2010 - 07/2009
3	Monoclonal AntibodiesIBA 01/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2010 - 01/2004
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 06/2009
2	CC ChemokinesIBA 01/2019 - 01/2018
2	mogamulizumabIBA 01/2019 - 01/2018
2	platelet-derived growth factor C (PDGF-C)IBA 02/2015 - 05/2014
2	AntigensIBA 01/2015 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 07/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2012 - 12/2010
2	AdiponectinIBA 05/2010 - 06/2007
2	PPAR alphaIBA 05/2010 - 11/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 01/2010
1	AntithrombinsIBA 01/2021
1	3-nitrotyrosineIBA 01/2020
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2020
1	hachimijiogan (TJ 7)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Choline (Choline Chloride)IBA 12/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2019
1	Methionine (L-Methionine)FDA Link 12/2019
1	canakinumab FDA Link 01/2019
1	Vorinostat FDA Link 01/2018
1	AT 61IBA 01/2018
1	vasectrin IIIIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 08/2016
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2016
1	Pharmaceutical PreparationsIBA 09/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2015
1	Neutralizing AntibodiesIBA 05/2014
1	Streptozocin (Streptozotocin)FDA Link 05/2014
1	AntioxidantsIBA 01/2014
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2014
1	Semaphorins (Semaphorin)IBA 10/2013
1	Chemotactic FactorsIBA 10/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013
1	CytokinesIBA 01/2013
1	boiogitoIBA 01/2013
1	bofu-tsusho-sanIBA 01/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2013
1	juzentaihotoIBA 01/2013

Therapy/Procedure

5	Kampo Medicine (Kampo) 01/2020 - 03/2010
5	Therapeutics 01/2019 - 07/2004
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
2	Injections 01/2015 - 01/2011
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2021
1	Acupuncture Points (Acupuncture Point) 12/2019
1	Percutaneous Collagen Induction 12/2019
1	Acupuncture Therapy 12/2019
1	Secondary Prevention 01/2019
1	Radiotherapy 01/2013
1	Traditional Medicine (Folk Remedies) 01/2013